The Global Therapeutic Respiratory Devices Market to Surge at a Significant CAGR of ~9% by 2027 | DelveInsight

The therapeutic respiratory devices market is expected to grow due to factors such as the rising prevalence of respiratory disorders such as COPD and asthma. Furthermore, an increasing geriatric population and increased tobacco and cigarette use over the last decade have fueled the therapeutic respiratory devices market growth. Moreover, product advancement due to R&D activities in this sector is another factor that will result in significant revenue growth in the therapeutic respiratory devices market.

LAS VEGAS, Feb. 14, 2023 /PRNewswire/ -- DelveInsight's Therapeutic Respiratory Devices Market Insights report provides the current and forecast market analysis, individual leading therapeutic respiratory devices companies' market shares, challenges, therapeutic respiratory devices market drivers, barriers, and trends, and key therapeutic respiratory devices companies in the market.

Key Takeaways from the Therapeutic Respiratory Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global therapeutic respiratory devices market during the forecast period. 
• Notable therapeutic respiratory devices companies such as Breas Medical AB, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, GE Healthcare, Hamilton Medical, Hill-Rom Services Inc. (Baxter), ICU Medical, Inc., Invacare Corporation, Koninklijke Philips N.V., Medtronic., ResMed, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Vyaire Medical, Inc., CAIRE Inc. (NGK SPARK PLUG CO., LTD.), Lind, Chart Industrie, DeVilbiss Healthcare, and several others are currently operating in the therapeutic respiratory devices market.
• In January 2023, ABM Respiratory Care received 510(k) clearance from the US Food and Drug Administration for its BiWaze Clear System (FDA). The new airway clearance system uses an innovative Dual Lumen Breathing Circuit to deliver Oscillating Lung Expansion (OLE) therapy.
• In July 2022, Omron Healthcare announced its latest advancement in the oxygen therapy category with the launch of a portable Oxygen concentrator. It is a medical molecular sieve-based concentrator providing a continuous supply of high-purity oxygen.
• In January 2022, a UK-based manufacturer of anesthesia equipment OES Medical launched a pioneering new mains-powered ICU ventilator to support hospitals manage oxygen demand at Arab Health 2022.

To read more about the latest highlights related to the therapeutic respiratory devices market, get a snapshot of the key highlights entailed in the Global Therapeutic Respiratory Devices Market Report

Therapeutic Respiratory Devices Overview

Therapeutic respiratory devices are primarily used in therapeutics to improve pulmonary functionalities by clearing the airway, increasing lung oxygen intake capacities, and assisting with mucous removal from the bronchi during respiratory therapeutics treatment. These respiratory devices are also used to aid in treating various chronic ailments associated with respiratory dysfunction. These ailments include chronic obstructive pulmonary disease (COPD), bronchitis, sleep disorders, asthma, and other chronic diseases. Several types of these devices are available on the market, each with a slightly different application purpose, such as long-term respiratory devices used primarily for intensive care, mobile home respiratory devices used in homecare settings, and portable respiratory devices used during an emergency to provide point-of-care assistance. Because of their wide range of applications, these devices are also used to facilitate and improve respiratory function in infants during postnatal care, particularly in preterm births, post-partum complications, and associated conditions.

Therapeutic Respiratory Devices Market Insights

North America is expected to lead the global therapeutic respiratory devices market in terms of revenue generation. The highest growth in the region is attributed to the rising prevalence of respiratory disorders. Aside from that, the presence of many key players in the North American therapeutic respiratory devices market is a key factor in the market share dominance. For instance, in January 2023, ABM Respiratory Care received 510(k) clearance from the US Food and Drug Administration for its BiWaze Clear System (FDA). The new airway clearance system uses an innovative Dual Lumen Breathing Circuit to deliver Oscillating Lung Expansion (OLE) therapy.

To know more about why North America is leading the market growth in the therapeutic respiratory devices market, get a snapshot of the Therapeutic Respiratory Devices Market Outlook 

Therapeutic Respiratory Devices Market Dynamics

The rising prevalence of respiratory disorders is one of the major factors driving the therapeutic respiratory devices market. Chronic respiratory diseases affect the airways and other lung structures. Chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases, and pulmonary hypertension are among the most common. Other risk factors besides tobacco smoke include air pollution, occupational chemicals and dust, and frequent lower respiratory infections during childhood. The rise in the prevalence of respiratory diseases has increased the therapeutic respiratory device market.

Furthermore, the growing geriatric population has increased the demand for therapeutic respiratory devices, as the chances of developing COPD increase with age due to a weakened immune system. In addition, various government responses to the alarming deaths caused by respiratory disorders have increased demand for the therapeutic respiratory device market, particularly in homecare settings, as the population is aware of these initiatives.

However, certain restraints to the growth of the therapeutic respiratory devices market include the high cost of launching new products, and product recalls and failures, which will act as barriers to the therapeutic respiratory devices market growth during the forecast period.

Additionally, with the increasing severity of the COVID-19 pandemic in early 2020, the therapeutic respiratory devices market demand skyrocketed. The increased occurrence of respiratory diseases due to the pandemic's consequences increased demand for therapeutic respiratory devices. Furthermore, increased investments by the government and major players to address the ventilator shortage resulted in numerous market launches. All of these factors have a positive impact on the therapeutic respiratory devices market growth. 

Get a sneak peek at the therapeutic respiratory devices market dynamics @ Therapeutic Respiratory Devices Market Dynamics Analysis

Therapeutic Respiratory Devices Market Assessment

• Therapeutic Respiratory Devices Market Segmentation
• Market Segmentation By  Product: Positive Airway Pressure Devices (Continuous Positive Airway Pressure Devices, Auto-Titrating Positive Airway Pressure Devices, Bi-Level Positive Airway Pressure Devices), Oxygen Concentrators (Fixed Oxygen Concentrators, Portable Oxygen Concentrators), Ventilators (Adult Ventilators, Neonatal Ventilators), Inhalers (Metered Dose Inhaler, Dry Powder Inhaler, Soft Mist Inhaler), Nebulizers (Compressor-Based Nebulizers, Piston-Based Hand-Held Nebulizers, Ultrasonic Nebulizers), Humidifiers (Heated Humidifiers, Passover Humidifiers, Integrated Humidifiers, Built-In Humidifiers, Standalone Humidifiers)
• Market Segmentation By  Application: Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, and Others
• Market Segmentation By End User: Hospital And Clinics, Home Care Settings, and Others
• Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the therapeutic respiratory devices market are set to emerge as the trendsetter explore @ Therapeutic Respiratory Devices Companies 

Table of Contents 

Interested in knowing the therapeutic respiratory devices market by 2027? Click to get a snapshot of the Therapeutic Respiratory Devices Market Trends

Related Reports

Severe Asthma Market

Severe Asthma Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key severe asthma companies, including AstraZeneca, Novartis, Sanofi, among others.

Asthma Pipeline

Asthma Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key asthma companies, including GSK, AstraZeneca, Teva Pharmaceuticals, among others.

Severe Asthma Pipeline 

Severe Asthma Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key severe asthma companies, including AstraZeneca, Novartis, Sanofi, among others.

Chronic Obstructive Pulmonary Disease Epidemiology Forecast

Chronic Obstructive Pulmonary Disease Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the chronic obstructive pulmonary disease epidemiology trends.

Chronic Obstructive Pulmonary Disease Market

Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key chronic obstructive pulmonary disease companies, including Sanofi, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Verona Pharma, among others.

Acute Respiratory Distress Syndrome Pipeline

Acute Respiratory Distress Syndrome Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key acute respiratory distress syndrome companies, including Bayer, Faron Pharmaceuticals, BioMarck Pharmaceuticals, among others.

Other Trending Reports

Tay-sachs Disease Or Gm2 Gangliosidosis Market | Onycholysis Market | Diagnostic Imaging Equipment Market | Chemotherapy-induced Peripheral Neuropathy Market | Global Electrophysiology Devices Market | Anaphylaxis Market | Atherectomy Devices Market | Helicobacter Pylori Infections Market | Ophthalmic Imaging Equipment Market | Androgenetic Alopecia Market | Allergic Rhinitis Market | Chronic Inflammatory Demyelinating Polyneuropathy Market | Chronic Inflammtory Demyelinating Polyneuropathy Market | Colorectal Cancer Crc Market | Opioid Induced Constipation Market | Vertigo Market | Bone Anchored Hearing Systems Market | Wound Closure Devices Market | Hip Replacement Devices Market | Hemodynamic Monitoring Systems Market | Egfr Non-small Cell Lung Cancer Market | Helicobacter Pylori Infection Market | Hyperkalemia Market | Polycythemia Market Neurostimulation Devices Market | Carpal Tunnel Syndrome Market | Ventilator Market | Cerebral Aneurysm Market | Alpha Antitrypsin Market | Binge Eating Disorder Market | Bunion Market | Concussions Market Size | Exocrine Pancreatic Insufficiency Market | Healthcare Due Diligence Services | Minimal Residual Disease Market | Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market

Related Healthcare Blogs

Emerging Therapies for Severe Asthma Treatment

COPD Treatment Market

COPD Epidemiological Trends

Chronic Respiratory Disease Market

Promising Therapies in the ARDS Market

Rising Acute Respiratory Distress Syndrome Prevalence

ARDS Market Outlook 

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect with us on LinkedIn|Facebook|Twitter

Additionally, get in touch with our business executive to explore @ Healthcare Due Diligence Services 

Contact Us

Shruti Thakur  
[email protected] 
+1(919)321-6187

https://www.delveinsight.com/medical-devices

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

SOURCE DelveInsight Business Research, LLP